All In Biotech

Drug Trial Radar · NCT00762671

Signaling Mechanisms and Vascular Function in Patients With Diabetes Mellitus

Last checked: Nov 19, 2026Latest source record: Sep 30, 2008 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

60

Actual

Start

May 1999

Primary completion

Oct 2007

Study completion Oct 2007

Sponsor

Lead sponsor
Brigham and Women's HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Sep 30, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Crossover
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Basic science
Who can join
All sexes, from 18 years, up to 85 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of the study is to learn how blood vessel function is altered by diabetes. We are studying an investigational drug, Ebselen, to see if it can improve the ability of blood vessels to relax (widen).

Conditions

  • Type 1 Diabetes Mellitus
  • Type 2 Diabetes Mellitus

Interventions

  • EbselenDrug

    150 mg BID for 2 weeks

  • PlaceboDrug

    Placebo 1 po BID for 2 weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Endothelium-dependent and endothelium-independent vasodilation of peripheral resistance and conduit vessels will be studied in diabetic (type 1 and 2) and healthy subjects two weeks following randomization to the ebselen or placebo.Time frame: one testing visit every 4 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Brigham and Women's Hosptial

    Boston, Massachusetts

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.